Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action

Detalles Bibliográficos
Autores principales: Cooper, Dan M., Rothstein, Mark A., Amin, Alpesh, Hirsch, Jan D., Cooper, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495825/
https://www.ncbi.nlm.nih.gov/pubmed/37706005
http://dx.doi.org/10.1017/cts.2023.612
_version_ 1785104976125624320
author Cooper, Dan M.
Rothstein, Mark A.
Amin, Alpesh
Hirsch, Jan D.
Cooper, Emma
author_facet Cooper, Dan M.
Rothstein, Mark A.
Amin, Alpesh
Hirsch, Jan D.
Cooper, Emma
author_sort Cooper, Dan M.
collection PubMed
description
format Online
Article
Text
id pubmed-10495825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104958252023-09-13 Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action Cooper, Dan M. Rothstein, Mark A. Amin, Alpesh Hirsch, Jan D. Cooper, Emma J Clin Transl Sci Perspective Cambridge University Press 2023-08-18 /pmc/articles/PMC10495825/ /pubmed/37706005 http://dx.doi.org/10.1017/cts.2023.612 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Perspective
Cooper, Dan M.
Rothstein, Mark A.
Amin, Alpesh
Hirsch, Jan D.
Cooper, Emma
Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title_full Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title_fullStr Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title_full_unstemmed Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title_short Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
title_sort unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: a call to action
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495825/
https://www.ncbi.nlm.nih.gov/pubmed/37706005
http://dx.doi.org/10.1017/cts.2023.612
work_keys_str_mv AT cooperdanm unintendedconsequencesofglucagonlikepeptide1receptoragonistsmedicationsinchildrenandadolescentsacalltoaction
AT rothsteinmarka unintendedconsequencesofglucagonlikepeptide1receptoragonistsmedicationsinchildrenandadolescentsacalltoaction
AT aminalpesh unintendedconsequencesofglucagonlikepeptide1receptoragonistsmedicationsinchildrenandadolescentsacalltoaction
AT hirschjand unintendedconsequencesofglucagonlikepeptide1receptoragonistsmedicationsinchildrenandadolescentsacalltoaction
AT cooperemma unintendedconsequencesofglucagonlikepeptide1receptoragonistsmedicationsinchildrenandadolescentsacalltoaction

Ejemplares similares